3 FDA Advisory Panel Members Resign Over Agency’s Approval of Alzheimer's Drug From Biogen

3 FDA Advisory Panel Members Resign Over Agency’s Approval of Alzheimer's Drug From Biogen

Three members of an independent panel that advised the U.S. FDA on nervous system drugs had resigned after the agency approved an Alzheimer's drug from Biogen.

Colorado Governor Signs Groundbreaking Medication Bill Into Law: Gives Terminally Ill Patients Access to Experimental Medicine

On Saturday, Colorado Gov. John Hickenlooper signed a groundbreaking bill into law, which gives terminally ill patients access to experimental medicine not yet approved by the Food and Drug Administration.

Doctors in United States, FDA Warn Against Use Of Generic Medications Manufactured In India Due To Quality Control Issues

A growing number of doctors in the United States have been voicing an increased concern over the quality of generic medications imported from India, according to a recent in-depth report from Reuters. The concerns weighing on the minds of many doctors in the U.S. come from an increasing trend of recalls and import bans put in place recently by the Food & Drug Administration (FDA) on drugs made in India.
Advertisement
Real Time Analytics